These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 33664867)

  • 1. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
    Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
    Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
    [No Abstract]   [Full Text] [Related]  

  • 2. KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription.
    Qin M; Han F; Wu J; Gao FX; Li Y; Yan DX; He XM; Long Y; Tang XP; Ren DL; Gao Y; Dai TY
    BMC Cancer; 2021 May; 21(1):559. PubMed ID: 34001062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma.
    Chen M; Jiang Y; Sun Y
    Biochem Biophys Res Commun; 2021 Apr; 550():77-83. PubMed ID: 33689883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin.
    He C; Sun J; Liu C; Jiang Y; Hao Y
    Clin Epigenetics; 2019 Jan; 11(1):8. PubMed ID: 30651137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
    Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
    Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
    Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
    Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Demethylase JARID1B Is Overexpressed in Osteosarcoma and Upregulates Cyclin D1 Expression via Demethylation of H3K27me3.
    Wang W; Zheng K; Pei Y; Zhang X
    Oncol Res; 2018 Apr; 26(3):373-384. PubMed ID: 28492139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
    Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
    Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
    Wan J; Liu Y; Long F; Tian J; Zhang C
    Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
    Dai G; Liu G; Zheng D; Song Q
    Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B.
    Xun J; Du L; Gao R; Shen L; Wang D; Kang L; Chen C; Zhang Z; Zhang Y; Yue S; Feng S; Xiang R; Mi X; Tan X
    Theranostics; 2021; 11(14):6847-6859. PubMed ID: 34093857
    [No Abstract]   [Full Text] [Related]  

  • 13. TET2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
    Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
    Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma.
    Wang H; Tao Y; Han J; Shen J; Mu H; Wang Z; Wang J; Jin X; Zhang Q; Yang Y; Lin J; Sun M; Ma X; Ren L; LeBlanc AK; Xu J; Hua Y; Sun W
    Cell Oncol (Dordr); 2024 Oct; 47(5):1845-1861. PubMed ID: 39115605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.
    Xiao Z; He Y; Liu C; Xiang L; Yi J; Wang M; Shen T; Shen L; Xue Y; Shi H; Liu P
    Oncol Rep; 2019 May; 41(5):2667-2678. PubMed ID: 30896884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of microRNA-326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting SMO expression.
    Huang JH; Xu Y; Lin FY
    J Cell Mol Med; 2020 Sep; 24(18):10876-10888. PubMed ID: 32743904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation.
    Lu S; Lu T; Zhang J; Gan L; Wu X; Han D; Zhang K; Xu C; Liu S; Qin W; Yang F; Wen W
    BMC Cancer; 2023 Mar; 23(1):290. PubMed ID: 36997926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib.
    Hou CH; Chen WL; Lin CY
    Cell Death Dis; 2024 May; 15(5):381. PubMed ID: 38816365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.
    Wang W; Wang B
    BMC Cancer; 2022 May; 22(1):562. PubMed ID: 35590288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.